[1]
Z. Hussein, F. S. Hui, L. Y. Nee, and N. L. Adam, “ASSESSING THE POTENTIAL OF DULAGLUTIDE IN DE-INTENSIFICATION OF BACKGROUND ORAL GLUCOSELOWERING DRUG (OGLD) AND INSULIN THERAPY IN MALAYSIANS WITH TYPE 2 DIABETES MELLITUS”, J ASEAN Fed Endocr Soc, vol. 39, no. S1, p. 23, Jul. 2024.